FGF18 and metastatic malignant neoplasm in the lymph nodes: In addition, the NSCLC patients with deep tumor invasion and/or larger tumors (T3–T4), high stages (stage III–IV), and lymph node metastasis (N1–N3) had higher FGF18 expression (Fig. 6d).